Pharmacology of new treatments for hyperkalaemia: patiromer and sodium zirconium cyclosilicate

Effect of Patiromer on Hyperkalemia Recurrence in Older Chronic Kidney Disease Patients Taking RAAS Inhibitors

(2018) Matthew R. Weir et al.   AMERICAN JOURNAL OF MEDICINE

Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis

(2018) Csaba P Kovesdy et al.   EUROPEAN HEART JOURNAL

The tolerability and safety profile of patiromer: a novel polymer-based potassium binder for the treatment of hyperkalemia

(2018) Bertram Pitt et al.   Expert Opinion On Drug Safety

Evaluation of the Potential for Drug Interactions With Patiromer in Healthy Volunteers

(2017) Lawrence J. Lesko et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Systematic Review and Meta-Analysis of Patiromer and Sodium Zirconium Cyclosilicate: A New Armamentarium for the Treatment of Hyperkalemia

(2017) Calvin J. Meaney et al.   PHARMACOTHERAPY

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN HEART JOURNAL

Mechanism of Action and Pharmacology of Patiromer, a Nonabsorbed Cross-Linked Polymer That Lowers Serum Potassium Concentration in Patients With Hyperkalemia

(2016) Lingyun Li et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Sodium Zirconium Cyclosilicate (ZS-9): A Novel Agent for the Treatment of Hyperkalemia

(2016) Kristin E. Linder et al.   PHARMACOTHERAPY

Patiromer: a clinical review

(2015) Ann G. Montaperto et al.   CURRENT MEDICAL RESEARCH AND OPINION

Maintenance of serum potassium with sodium zirconium cyclosilicate (ZS-9) in heart failure patients: results from a phase 3 randomized, double-blind, placebo-controlled trial

(2015) Stefan D. Anker et al.   EUROPEAN JOURNAL OF HEART FAILURE

Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease

(2015) George L. Bakris et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient

(2015) Stephen R. Ash et al.   KIDNEY INTERNATIONAL

Patiromer in Patients with Kidney Disease and Hyperkalemia Receiving RAAS Inhibitors

(2015) Matthew R. Weir et al.   NEW ENGLAND JOURNAL OF MEDICINE

Sodium Zirconium Cyclosilicate in Hyperkalemia

(2015) David K. Packham et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of Sodium Zirconium Cyclosilicate on Potassium Lowering for 28 Days Among Outpatients With Hyperkalemia

(2014) Mikhail Kosiborod et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Characterization of Structure and Function of ZS-9, a K+ Selective Ion Trap

(2014) Fiona Stavros et al.   PLoS One

Asking the question again: are cation exchange resins effective for the treatment of hyperkalemia?

(2012) K. S. Kamel et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Evaluation of the efficacy and safety of RLY5016, a polymeric potassium binder, in a double-blind, placebo-controlled study in patients with chronic heart failure (the PEARL-HF) trial

(2011) B. Pitt et al.   EUROPEAN HEART JOURNAL

Ion-Exchange Resins for the Treatment of Hyperkalemia: Are They Safe and Effective?

(2010) R. H. Sterns et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY